细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2822人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979220, encodeId=178219e9220ac, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：TACE联合索拉非尼或阿帕替尼治疗伴有门脉癌栓（PVTT）的肝细胞癌（HCC）患者的疗效, objectType=article, longId=219192, objectId=ab6d21919256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6d21919256, replyNumber=0, likeNumber=76, createdTime=2022-06-16, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6d21919256, moduleTitle=Front Oncol：TACE联合索拉非尼或阿帕替尼治疗伴有门脉癌栓（PVTT）的肝细胞癌（HCC）患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab6d21919256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979157, encodeId=3df919e915734, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效, objectType=article, longId=213475, objectId=ae672134e56d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae672134e56d, replyNumber=0, likeNumber=51, createdTime=2022-03-20, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae672134e56d, moduleTitle=Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae672134e56d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979174, encodeId=ba1419e9174a2, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Cancer：SLC38A4调控Wnt/β-catenin/MYC/HMGCS2信号通路抑制肝细胞癌的发生发展, objectType=article, longId=214725, objectId=854e214e25ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=854e214e25ee, replyNumber=0, likeNumber=82, createdTime=2022-06-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=854e214e25ee, moduleTitle=Br J Cancer：SLC38A4调控Wnt/β-catenin/MYC/HMGCS2信号通路抑制肝细胞癌的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=854e214e25ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979213, encodeId=e84419e92134f, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Hepatol：一种预测韩国和高加索慢性乙型肝炎患者肝细胞癌风险的人工智能模型：PLAN-B, objectType=article, longId=218649, objectId=b92d2186494a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b92d2186494a, replyNumber=0, likeNumber=76, createdTime=2021-12-21, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b92d2186494a, moduleTitle=J Hepatol：一种预测韩国和高加索慢性乙型肝炎患者肝细胞癌风险的人工智能模型：PLAN-B, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b92d2186494a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979210, encodeId=aca019e92103c, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Cancer：基于白蛋白胆红素（ALBI）分级评估卡博替尼（cabozantinib）治疗晚期肝细胞癌（HCC）的疗效和安全性, objectType=article, longId=218274, objectId=25462182e412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25462182e412, replyNumber=0, likeNumber=62, createdTime=2022-02-04, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25462182e412, moduleTitle=Br J Cancer：基于白蛋白胆红素（ALBI）分级评估卡博替尼（cabozantinib）治疗晚期肝细胞癌（HCC）的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25462182e412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979235, encodeId=054919e9235f5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：nivolumab + ipilimumab对比舒尼替尼治疗晚期肾细胞癌（aRCC）患者后的无治疗生存时间（TFS）对比：来自Check- Mate 214研究结果, objectType=article, longId=220254, objectId=cfa922025489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfa922025489, replyNumber=0, likeNumber=56, createdTime=2021-12-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfa922025489, moduleTitle=Clin Cancer Res：nivolumab + ipilimumab对比舒尼替尼治疗晚期肾细胞癌（aRCC）患者后的无治疗生存时间（TFS）对比：来自Check- Mate 214研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfa922025489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979085, encodeId=5b2119e9085b1, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Int：慢性肝病肝细胞癌晚期复发的病理预测因素, objectType=article, longId=207805, objectId=286920e80512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=286920e80512, replyNumber=0, likeNumber=126, createdTime=2021-04-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=286920e80512, moduleTitle=Liver Int：慢性肝病肝细胞癌晚期复发的病理预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=286920e80512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979065, encodeId=4d4519e90653e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cell Death Differ：PIWIL2通过与IKK相互作用调节食管鳞状细胞癌细胞自噬和凋亡的发生, objectType=article, longId=206037, objectId=218e20603ea4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=218e20603ea4, replyNumber=0, likeNumber=96, createdTime=2021-05-22, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=218e20603ea4, moduleTitle=Cell Death Differ：PIWIL2通过与IKK相互作用调节食管鳞状细胞癌细胞自噬和凋亡的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=218e20603ea4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979249, encodeId=b46819e92496a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：中性粒细胞/淋巴细胞比值(NLR)与avelumab联合阿昔替尼或舒尼替尼治疗晚期肾细胞癌（RCC）疗效的关系: 来自JAVELIN Renal 101研究, objectType=article, longId=221216, objectId=48642212160d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48642212160d, replyNumber=0, likeNumber=61, createdTime=2022-07-07, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48642212160d, moduleTitle=Clin Cancer Res：中性粒细胞/淋巴细胞比值(NLR)与avelumab联合阿昔替尼或舒尼替尼治疗晚期肾细胞癌（RCC）疗效的关系: 来自JAVELIN Renal 101研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48642212160d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979229, encodeId=0f4419e9229fa, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet Oncol：放疗可推迟寡转移肾细胞癌的系统治疗时间, objectType=article, longId=219782, objectId=255f219e821e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=255f219e821e, replyNumber=0, likeNumber=64, createdTime=2021-11-22, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=255f219e821e, moduleTitle=Lancet Oncol：放疗可推迟寡转移肾细胞癌的系统治疗时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=255f219e821e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979214, encodeId=de0519e921453, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAAD:如何区分刺激性脂溢性角化病与鳞状细胞癌, objectType=article, longId=219020, objectId=1feb21902079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1feb21902079, replyNumber=0, likeNumber=44, createdTime=2022-05-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1feb21902079, moduleTitle=JAAD:如何区分刺激性脂溢性角化病与鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1feb21902079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979173, encodeId=ea1019e917364, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：重新定义中期肝细胞癌的肿瘤负荷：7-11标准, objectType=article, longId=214678, objectId=deda2146e818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deda2146e818, replyNumber=0, likeNumber=52, createdTime=2022-04-06, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deda2146e818, moduleTitle=Liver Cancer：重新定义中期肝细胞癌的肿瘤负荷：7-11标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deda2146e818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979195, encodeId=1a9419e919545, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据, objectType=article, longId=217450, objectId=f9a121e450ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9a121e450ea, replyNumber=0, likeNumber=70, createdTime=2021-11-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9a121e450ea, moduleTitle=Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9a121e450ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979119, encodeId=7de119e91193b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JEADV：Hh通路抑制剂Vismodegib在临床实践中治疗局部晚期基底细胞癌的有效性, objectType=article, longId=211026, objectId=234e21102685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=234e21102685, replyNumber=0, likeNumber=106, createdTime=2021-09-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=234e21102685, moduleTitle=JEADV：Hh通路抑制剂Vismodegib在临床实践中治疗局部晚期基底细胞癌的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=234e21102685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979167, encodeId=5bb119e916799, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, objectType=article, longId=214297, objectId=744721429ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744721429ee4, replyNumber=0, likeNumber=94, createdTime=2021-09-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744721429ee4, moduleTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744721429ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979080, encodeId=77b019e90800d, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究, objectType=article, longId=207381, objectId=313020e38117, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313020e38117, replyNumber=0, likeNumber=10, createdTime=2021-06-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313020e38117, moduleTitle=Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=313020e38117)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979144, encodeId=7df619e91447c, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Radiology:扩散加权MRI成像，使VHL相关性肾透明细胞癌的个性化检测成为可能, objectType=article, longId=212581, objectId=94af212581cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94af212581cc, replyNumber=0, likeNumber=52, createdTime=2022-04-14, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94af212581cc, moduleTitle=Radiology:扩散加权MRI成像，使VHL相关性肾透明细胞癌的个性化检测成为可能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94af212581cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979106, encodeId=0b8b19e910614, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响, objectType=article, longId=209642, objectId=0bbc2096428f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bbc2096428f, replyNumber=0, likeNumber=69, createdTime=2021-06-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bbc2096428f, moduleTitle=World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bbc2096428f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979248, encodeId=1aa019e9248e6, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Immunother Cancer：PD-L1抑制剂avelumab联合/不联合西妥昔单抗治疗既往治疗过的晚期肛管鳞状细胞癌(aSCAC)患者的疗效和安全性：CARACAS研究, objectType=article, longId=221205, objectId=3c79221205ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c79221205ea, replyNumber=0, likeNumber=84, createdTime=2022-09-15, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c79221205ea, moduleTitle=J Immunother Cancer：PD-L1抑制剂avelumab联合/不联合西妥昔单抗治疗既往治疗过的晚期肛管鳞状细胞癌(aSCAC)患者的疗效和安全性：CARACAS研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c79221205ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979060, encodeId=6b6d19e90600a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Gastro: 糖尿病患者肝细胞癌的发生几率分析, objectType=article, longId=205855, objectId=a22d2058557b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a22d2058557b, replyNumber=0, likeNumber=77, createdTime=2021-06-21, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a22d2058557b, moduleTitle=J Gastro: 糖尿病患者肝细胞癌的发生几率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a22d2058557b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：TACE联合索拉非尼或阿帕替尼治疗伴有门脉癌栓（PVTT）的肝细胞癌（HCC）患者的疗效

2022-06-16

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效

2022-03-20

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Cancer：SLC38A4调控Wnt/β-catenin/MYC/HMGCS2信号通路抑制肝细胞癌的发生发展

2022-06-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Hepatol：一种预测韩国和高加索慢性乙型肝炎患者肝细胞癌风险的人工智能模型：PLAN-B

2021-12-21

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Cancer：基于白蛋白胆红素（ALBI）分级评估卡博替尼（cabozantinib）治疗晚期肝细胞癌（HCC）的疗效和安全性

2022-02-04

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：nivolumab + ipilimumab对比舒尼替尼治疗晚期肾细胞癌（aRCC）患者后的无治疗生存时间（TFS）对比：来自Check- Mate 214研究结果

2021-12-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Int：慢性肝病肝细胞癌晚期复发的病理预测因素

2021-04-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cell Death Differ：PIWIL2通过与IKK相互作用调节食管鳞状细胞癌细胞自噬和凋亡的发生

2021-05-22

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：中性粒细胞/淋巴细胞比值(NLR)与avelumab联合阿昔替尼或舒尼替尼治疗晚期肾细胞癌（RCC）疗效的关系: 来自JAVELIN Renal 101研究

2022-07-07

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet Oncol：放疗可推迟寡转移肾细胞癌的系统治疗时间

2021-11-22

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAAD:如何区分刺激性脂溢性角化病与鳞状细胞癌

2022-05-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：重新定义中期肝细胞癌的肿瘤负荷：7-11标准

2022-04-06

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur J Cancer：Cemiplimab治疗局部晚期/转移性皮肤鳞状细胞癌的真实数据

2021-11-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JEADV：Hh通路抑制剂Vismodegib在临床实践中治疗局部晚期基底细胞癌的有效性

2021-09-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系

2021-09-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur J Cancer：局部晚期头颈鳞状细胞癌老年患者强化放疗激活NBTXR3的I期剂量递增研究

2021-06-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Radiology:扩散加权MRI成像，使VHL相关性肾透明细胞癌的个性化检测成为可能

2022-04-14

qingting (审核中...)

前往app查看评论内容

#细胞癌#

World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响

2021-06-05

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Immunother Cancer：PD-L1抑制剂avelumab联合/不联合西妥昔单抗治疗既往治疗过的晚期肛管鳞状细胞癌(aSCAC)患者的疗效和安全性：CARACAS研究

2022-09-15

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Gastro: 糖尿病患者肝细胞癌的发生几率分析

2021-06-21

科室
- - 订阅+
  - 更多科室
工具
服务